Additionally, our study found that the expression of ASRGL1 and EREG can influence the sensitivity of colon cancer to certain antitumor drugs, and the specific mechanisms underlying these effects warrant further exploration. The gene discussed is ASRGL1; the disease is colonic neoplasm.